Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02088190 · ClinicalTrials.gov registry record
Effect of Aging on Bariatric Surgery-induced Changes in Metabolism and Cognition
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 11
- Enrollment target
NCT02088190: Completed study, sponsored by Ohio State University.
NCT02088190 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02088190 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The investigators hypothesize that the improvements in insulin sensitivity, beta (β)-cell function, and inflammation will be greater, and the improvement in sarcopenic obesity will be less, in younger versus older individuals after substantial weight loss induced by sleeve gastrectomy bariatric surgery.
Primary Outcome
Subjects will undergo a clamp procedure to assess insulin sensitivity at baseline and 15% weight loss after surgery
Interventions
- PROCEDURE Sleeve gastrectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-04 |
| Est. Completion | 2021-07 |
What the finished NCT02088190 record still lists
NCT02088190 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Sleeve gastrectomy is the first listed.
NCT02088190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02088190 about?
NCT02088190 is a clinical study titled "Effect of Aging on Bariatric Surgery-induced Changes in Metabolism and Cognition". The investigators hypothesize that the improvements in insulin sensitivity, beta (β)-cell function, and inflammation will be greater, and the improvement in sarcopenic obesity will be less, in younger versus older individuals after substantial weight loss induced by sleeve gastrectomy bariatric surg...
What is the current status of trial NCT02088190?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2014-04. Estimated completion is 2021-07.
What interventions are being tested in trial NCT02088190?
The interventions under investigation include: Sleeve gastrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02088190?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia